BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6782875)

  • 21. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemobiological activity of gliclazide in diabetes mellitus.
    Ziegler O; Drouin P
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S83-9. PubMed ID: 1794271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive and therapeutic effects of gliclazide on diabetic retinopathy: comparison with glibenclamide treatment.
    Minami N; Ikeda Y; Abe M
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():707-11. PubMed ID: 6440314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
    Arfors KE; Bergqvist D; Tangen O
    Ups J Med Sci; 1980; 85(1):74-83. PubMed ID: 7385462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):154-8. PubMed ID: 3080539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes.
    Malyszko J; Urano T; Knofler R; Taminato A; Yoshimi T; Takada Y; Takada A
    Thromb Res; 1994 Sep; 75(5):569-76. PubMed ID: 7992257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of diamicron on various blood coagulation indices in patients with type II diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Novikova NV; Nepsha VD
    Klin Med (Mosk); 1983 Apr; 61(4):66-8. PubMed ID: 6865293
    [No Abstract]   [Full Text] [Related]  

  • 30. Synergism between collagen-adenosine diphosphate and collagen-epinephrine in platelets' aggregation: different dose response relationships.
    Razi MS; Hameed W; Habib SS; Aslam M; Ashraf R
    J Pak Med Assoc; 2009 Jun; 59(6):368-71. PubMed ID: 19534370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative evaluation of the hypoglycemic effect of the 2d-generation sulfonylurea preparations maninil and diamicron in diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Levitskaia ZI; Gincherman LE
    Probl Endokrinol (Mosk); 1982; 28(5):9-11. PubMed ID: 6815639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with diamicron treatment of diabetics].
    Velikov VK; Shubina IO; Saltykov BB; Frolova AI
    Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelets and diabetic vascular disease.
    Paton RC; Passa P
    Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole blood platelet aggregation in humans and animals: a comparative study.
    Soloviev MV; Okazaki Y; Harasaki H
    J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic].
    Brogard JM; Pinget M; Leconte A; Dorner M
    Rev Med Interne; 1982 Dec; 3(4):379-87. PubMed ID: 6761818
    [No Abstract]   [Full Text] [Related]  

  • 37. An evaluation of the effects of some sulphonylureas on platelet function.
    King JB; Kalk WJ; Vinik AI; Jackson WP; Bracher M; Jacobs P
    S Afr Med J; 1977 Jan; 51(5):124-6. PubMed ID: 322325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered in vitro functions of platelets prepared by the Haemonetics blood processor.
    Ts'ao CH; Wirman JA; Ruder EA
    J Lab Clin Med; 1975 Aug; 86(2):315-25. PubMed ID: 1151154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagen-induced platelet aggregation:--evidence against the essential role of platelet adenosine diphosphate.
    Nunn B
    Thromb Haemost; 1979 Dec; 42(4):1193-206. PubMed ID: 542929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular benefits of gliclazide beyond glycemic control.
    Jennings PE
    Metabolism; 2000 Oct; 49(10 Suppl 2):17-20. PubMed ID: 11078471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.